Literature DB >> 24748443

Association between vitamin D status and COPD phenotypes.

Mia Moberg1, Thomas Ringbaek, Nassim Bazeghi Roberts, Jørgen Vestbo.   

Abstract

BACKGROUND: It has been suggested that identifying phenotypes in chronic obstructive pulmonary disease (COPD) might improve treatment outcome and the accuracy of prediction of prognosis. In observational studies vitamin D deficiency has been associated with decreased pulmonary function, presence of emphysema and osteoporosis, upper respiratory tract infections, and systemic inflammation. This could indicate a relationship between vitamin D status and COPD phenotypes. The aim of this study was to assess the association between vitamin D levels and COPD phenotypes. In addition, seasonality of vitamin D levels was examined.
METHODS: A total of 91 patients from a Danish subpopulation of the "Evaluation of COPD Longitudinally to Identify Predictive Surrogate End-points" cohort took part in a biomarker substudy. Vitamin D concentration was measured from blood samples taken at two visits, approximately 6 months apart. The participants were 40-75-year-old patients with COPD and had a smoking history of >10 pack-years.
RESULTS: Fifty-six patients had 25-hydroxyvitamin D measured from blood samples from both visits. In the final model of the multivariate analyses, the factors that were associated with vitamin D deficiency at the first visit were age (OR: 0.89, p = 0.02) and summer season (OR: 3.3, p = 0.03). Factors associated with vitamin D level also at the first visit were age (B: 0.9, p = 0.02) and 6 min walking distance (B: 0.05, p = 0.01).
CONCLUSION: Vitamin D was not associated with COPD phenotypes and season did not seem to be a determinant of vitamin D levels in patients with moderate to severe COPD.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24748443     DOI: 10.1007/s00408-014-9582-9

Source DB:  PubMed          Journal:  Lung        ISSN: 0341-2040            Impact factor:   2.584


  19 in total

1.  Seasonality of vitamin D status in older people in Southern Germany: implications for assessment.

Authors:  Jochen Klenk; Kilian Rapp; Michael Dieter Denkinger; Gabriele Nagel; Thorsten Nikolaus; Richard Peter; Wolfgang Koenig; Bernhard Otto Böhm; Dietrich Rothenbacher
Journal:  Age Ageing       Date:  2013-03-29       Impact factor: 10.668

2.  Vitamin D: marker or mechanism of action?

Authors:  Elizabeth T Jacobs; María Elena Martínez; Peter W Jurutka
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2011-04       Impact factor: 4.254

3.  Exhaled nitric oxide measure using multiple flows in clinically relevant subgroups of COPD.

Authors:  Nassim Bazeghi; Thomas A Gerds; Esben Budtz-Jørgensen; Jens Hove; Jørgen Vestbo
Journal:  Respir Med       Date:  2011-05-06       Impact factor: 3.415

Review 4.  Vitamin D and inflammation.

Authors:  Xavier Guillot; Luca Semerano; Nathalie Saidenberg-Kermanac'h; Géraldine Falgarone; Marie-Christophe Boissier
Journal:  Joint Bone Spine       Date:  2010-11-09       Impact factor: 4.929

5.  High doses of vitamin D to reduce exacerbations in chronic obstructive pulmonary disease: a randomized trial.

Authors:  An Lehouck; Chantal Mathieu; Claudia Carremans; Femke Baeke; Jan Verhaegen; Johan Van Eldere; Brigitte Decallonne; Roger Bouillon; Marc Decramer; Wim Janssens
Journal:  Ann Intern Med       Date:  2012-01-17       Impact factor: 25.391

Review 6.  COPD and osteoporosis.

Authors:  Diane M Biskobing
Journal:  Chest       Date:  2002-02       Impact factor: 9.410

7.  Association between serum 25-hydroxyvitamin D level and upper respiratory tract infection in the Third National Health and Nutrition Examination Survey.

Authors:  Adit A Ginde; Jonathan M Mansbach; Carlos A Camargo
Journal:  Arch Intern Med       Date:  2009-02-23

8.  Serum 25-hydroxyvitamin D status of the US population: 1988-1994 compared with 2000-2004.

Authors:  Anne C Looker; Christine M Pfeiffer; David A Lacher; Rosemary L Schleicher; Mary Frances Picciano; Elizabeth A Yetley
Journal:  Am J Clin Nutr       Date:  2008-12       Impact factor: 7.045

9.  Vitamin D and skeletal muscle strength and endurance in COPD.

Authors:  Abigail S Jackson; Dinesh Shrikrishna; Julia L Kelly; Samuel V Kemp; Nicholas Hart; John Moxham; Michael I Polkey; Paul Kemp; Nicholas S Hopkinson
Journal:  Eur Respir J       Date:  2012-05-03       Impact factor: 16.671

10.  Supplemental vitamin D and physical performance in COPD: a pilot randomized trial.

Authors:  Sonja M Bjerk; Bradley D Edgington; Thomas S Rector; Ken M Kunisaki
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2013-02-15
View more
  4 in total

1.  Vitamin D Deficiency Does Not Result in a Breach of Host Defense in Murine Models of Pneumonia.

Authors:  Julia Niederstrasser; Christian Herr; Lisa Wolf; Claus M Lehr; Christoph Beisswenger; Robert Bals
Journal:  Infect Immun       Date:  2016-10-17       Impact factor: 3.441

2.  Osteoporosis in chronic obstructive pulmonary disease.

Authors:  Sim Sai Tin; Viroj Wiwanitkita
Journal:  Lung India       Date:  2015 Mar-Apr

3.  Relationship between vitamin D-binding protein polymorphisms and blood vitamin D level in Korean patients with COPD.

Authors:  Youngmok Park; Young Sam Kim; Young Ae Kang; Ju Hye Shin; Yeon Mok Oh; Joon Beom Seo; Ji Ye Jung; Sang Do Lee
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2016-04-07

4.  Vitamin D status and distribution in patients with chronic obstructive pulmonary disease versus healthy controls.

Authors:  Behzad Heidari; Yahya Javadian; Mahmoud Monadi; Yahya Dankob; Alireza Firouzjahi
Journal:  Caspian J Intern Med       Date:  2015
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.